Despite trying antidepressants and CBT, the “panic” episodes only worsened, especially in the three years before the test.

Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct ...

The AMG TimesSquare Small Cap Growth Fund outperformed its benchmark in Q4 2025 behind strong tech and industrial gains. Read ...

U.S. stocks slumped after a report said inflation was primed to worsen even before the war with Iran sent oil prices spiking. That and comments from the head of the ...

The AMG TimesSquare Fund outperformed its benchmark in Q4 2025 amid economic shifts. Read the full analysis for more details.